Dr Salim Shafeek

 Professional experience

• More than 30 years of experience
• Former clinical director of Haemato-Oncology, Worcestershire Acute NHS Trust (Teaching)
• Consultant Haematologist, Harborne Hospital, HCA Healthcare, Birmingham (present)
• Consultant Haematologist, BMI Priory Edgbaston (present)
• ​Consultant Haematologist, BMI The Droitwich Spa Hospital (present)
• Consultant Haematologist, Spire Southbank, Worcester (present)
• Clinical Trial Experience, Chief Trial Haematology Lead for Worcestershire Acute Trust (present)
• Consultant TDL laboratory staff, BMI Priory Hospital in Birmingham (present)

...

 Sub-specialties

• Leukaemia
• Lymphoma
• Myeloma
• Myeloproliferative disorder
• Anaemia
• Thrombosis
• Haemostasis
• Aplastic anaemia
• Bleeding disorders
• Bone marrow transplant aspirate
• Essential thrombocythaemia
• Haemochromatosis
• Haemoglobinuria
• Hodgkin's disease
• Iron metabolism
• Myelodysplastic syndrome
• Myelofibrosis
• Myeloproliferative disorders
• Platelets disorders
• Polycythaemia vera
• Purpura
• Paroxysmal Nocturnal Haemoglobinuria (PNH)
• Thalassaemia
• Thrombocytopenia
• Thrombosis – PE/DVT
• Obstetric Haematology – Thrombosis / Haemostasis
• Waldenstrom's macroglobulinaemia
• Trephine biopsy

...

 Positions in public associations

• Principal Investigator for National Clinical Trials (NCRI-UK)

 Teaching posts

• Senior Lecturer in Clinical Haematology, University of Birmingham (present)
• Medical Advisory Panel for treatment in CLL (2009)
• Examiner, MRCP Paces for Royal College of Physicians, London, Edinburgh and Glasgow (2008 - 2024)
• Examiner for Royal College of Pathology (FRCPath London)
• Offers courses to GPs, medical students, postgraduate students and junior medical staff

...

 Education

• FRCPath (Haematology) Royal College of Pathology, London (2002)
• FRCP (Edinburgh) Royal College of Physicians, Edinburgh (1999)
• FRCP Royal College of Physicians, London (1998)
• DipRCPath Royal College of Pathology (1997)
• MD University of Calicut, Kerala (1989)

...

 Publications and conferences

• Has published many articles in peer-reviewed journals.
• Reviewer for Cancer Peer Review.
• Presents both nationally and internationally.
• DEFINING THE DOSE OF GEMTUZUMAB(OZOGAMICIN) IN AML A COMPARITIVE RANDOMISED STUDY MRC AML 17 TRIAL. ALAN BURNETT, JAMIE CAVENAGH, NIGEL RUSSELL ET AL – ACKNOWLEDGEMENT SALIM SHAFEEK (WORCESTERSHIRE ROYAL TRUST. HAEMATOLOGICA FEB 2016
• ADDITION OF GEMTUZUMAB (OZOGAMICIN) TO INDUCTION CHEMOTHERAPY IMPROVES SURVIVAL IN OLDER PATIENTS WITH AML-MRC AML TRIAL DATA- JCO 30TH JULY 2012 PROF ALAN BURNETT, CHARLIE CRADDOCK, DON MILLIGAN ET AL – ACKNOWLEGEMENT –SALIM SHAFEEK (WORCESTERSHIRE ROYAL HOSPITAL)
• PROSPECTIVE MRD MONITORING TO PREDICT RELAPSE OF APML & TO DIRECT PREEMTIVE ARSENIC TRIOXIDE TREATMENT –MRC AML 15 TRIAL PROF DAVID GRIMWADE ET AL – ACKOWLEDGEMENT SALIM SHAFEEK (WORCESTERSHIRE ROAYL HOSPITAL) JCO 9TH FEB 2009
• FIRST-LINE TREATMENT WITH ZOLEDRONIC ACID AS COMPARED WITH ORAL CLODRONATE IN MULTIPLE MYELOMA(MRC MYELOMA IX) AS RANDOMISED CONTROLLED TRIAL: LANCET 376 (0757) PP 1989-1999 GARETH MORGAN , FAITH DAVIES ET AL- SALIM SHAFEEK (WORCESTESHIRE ROYAL HOSPITAL)
• Image in Blood Med. Pamidronate induced osteonecrosis of the jaw in a myeloma patient. S.Paneesha,S.Shafeek,N.Barnard,U.Udeshi. https://www.bloodmed.com/education/case1.asp?id=194.
• Image in Blood Med. Variant acute promyelocytic leukaemia presenting with massive intracerebral haemorrhage. S Paneesha, S Shafeek, C Phillips and R Stockley https://www.bloodmed.com/education/case1.asp?id=195.
• CLIMATIC INFLUENCE ON HAEMOGLOBIN LEVELS OF BLOOD DONORS. SHAFEEK S, BECKMAN N. SMITH N, GABRA G, TRANSFUSION TODAY, NO. 28. SEPTEMBER 1996, PAGE 6-8.
• TREATMENT OF ANAEMIA OF PROGRESSIVE RENAL FAILURE WITH RECOMBINANT ERYTHROPOIETIN - A PRELIMINARY REPORT. SALIM K.A, SHAFEEK S, MATHEW T.J.ASSO PHYSICIANS OF INDIA, VOL 40, PAGE 42-3, JANUARY 1992.
• CHICKENPOX INDUCED PANCYTOPENIA AND PROMPT RESPONSE TO HIGH DOSE INTRAVENOUS IMMUNOGLOBULIN. SHAFEEK. S, SALIM K.A, JAPI, VOL 40, NO. 10: PAGE 689-690 1992.
• ANTIPHOSPHOLIPID ANTIBODY SYNDROME OF SLE PRESENTING AS DEEP THROMBOSIS. SHAFEEK.S,SALIM.K.A. JAPI,FEBRUARYL992,VOL4O,NO2,PAGE 125-126.
• NON-HODGKIN'S LYMPHOMA PRESENTING AS PURE RED CELL APLASIA. SHAFEEK S, SALIM.K.A, JAPI, VOL. 40. NO. 11. PAGE 765 - 766. 1992
• The Quadruplet Combination of Carfilzomib, Cyclophosphamide , Lenalidomide and dexamethasone is safe and well tolerated as induction therapy for Newly diagnosed , transplant eligible Myeloma patients (Myeloma XI+ trial UK) Faith Davies , Nigel Russell, Gordon Cook , Donald Milligan , Salim Shafeek , Gareth Morgan et al EHA 12th June 2015 Oral presentation.
• The UK & Ireland Perspective of Relapsed refractory Multiple Myeloma(PASS) treated with Lenalidomide, Bortezomib & Thalidomide. Multicenter Observational PASS study. Poster EHA 2014 Jenny Bird, Salim Shafeek, John Ashcroft, Roger Owen & Graham Jackson
• Toxicity & Efficacy of Bendamustine in CLL & Indolent NHL – A Multicenter observational of real life experience in UK. Poster EHA 2015 Duncan Murray, Supratik Basu, Salim Shafeek, Sridhar Chaganti, Shankara Paneesha & Sebastian Francis
• High dose ARA-C/Amsacrine as salvage therapy in Acute leukaemias- Regional transplant centre experience .S. Paneesha, S.Shafeek, P.Mahendra, C.Craddock.(BSH Poster - April 2002 )
• Two cases of Post Transfusion Hyperhaemolysis in Sickle cell disease. S.Shafeek, M.Jabbar, M.J.Strevens,D.Bareford ,N.Smith ;British Journal of Haematology ,Suppl 1 March 2000: Page 38.
• A baby with combined hyperlipidaemia presenting as Anaemia & Milky Blood Salim K.A. Shafeek S, Blood Vol 76, No. 10: 46a. Suppl: November 15th 1990
• A case of haemolysis due to excess serum copper possibly from dietary sources in a patient having Low serum Caeruloplasmin. Salim K.A, Shafeek.S. Blood Vol 76, No 10, 46a, suppl: Nov 15th 1990.
• Effect of short course Alpha Interferon in chronic myelogenous leukaemia. Salim K.A, Shafeek S, Sathianathan P. Abstract – British Joumal of Haematology, August 1992 (ISH Special)
• An unusual case of eosinophilic granuloma (Langerhans Cell Granuloma) -1991 - API Agra, India. Salim K.A, Shafeek S. Presented at Asso Physicians of India National Conference.
• Ondansetron versus high dose metoclopramide in Chemotherapy induced nausea and vomiting - A preliminary report. Salim K.A., Shafeek. S, Sathyanathan P. Presented at API National Conference April 1992.
• Mucor Mycotic Osteitis and Rhinocerebral mucormycosis in a diabetic patient with Diabetiv Ketoacidosis. Shafeek, Salim KA- Presented at API meeting,April1992
• A clinical profile of acute intermittent Porphyria - twelve cases. Salim K.A, Shafeek. S, Sathyanathan P, Paper Presented at API January 1993.
• An unusual case of systemic amyloidosis and plasma cell dyscrasia in a 62 year old man. Salim K.A., Shafeek S., Sathyanathan P. Paper presented for API, January 1993.
• Pseudotumour of right leg in a patient with haemophilia - A. Salim K.A. Shafeek, Sathyanathan P, paper presented for API January 1993.
• Effect of ondansetron (5H3 receptor antagonist) in the relief of symptoms in malignant Carcinoid syndrome. Salim. K.A., Shafeek. S, Manoj. C. Paper presented for API January 1992.
• Clinical effect of octreotide (Sandostatin) in controlling the symptoms of Malignant carcinoid syndrome. Salim. K.A, Shafeek. S, Manoj. S. Paper presented for API January 1993.
• Lymes Disease - Calicut Experience. Salim. K.A, Shafeek. S. Sathyanathan. P. Paper presented for API January 1993.
• Lenalidomide Induction and Maintenance for Transplant-Eligible Patients of All Ages with Newly Diagnosed Multiple Myeloma (2018)

...

 Prizes and awards

• Winner, G.K.Warrier Memorial Gold Medal, First rank in Postgraduate Medicine, University of Calicut (1992)
• Best Outgoing Postgraduate Student in Medicine, University of Calicut (1992)
• Indian Association of Paediatrics Quiz, runner-up (1987)
• Clinical Excellence Awards (CEA) - Level 9 (Equivalent to Bronze nationally)

...

 Professional membership

• Member of British and American Society of Haematology
• Fellow of Royal College of Physicians, London & Edinburgh
• Fellow of Royal College of Pathology, London
• Member of UK Myeloma Forum
• Member of UK CLL Forum
• Member of UK Thromboprophylaxis Forum
• Member of Associations of Physicians, India

...